Researchers from the University of Massachusetts Amherst and Cyta Therapeutics, Inc. (Lowell, MA) have used a nanogel-based carrier to deliver a drug exclusively to the liver of obese mice, effectively reversing their diet-induced disease. The researchers gave the drug – which mimics a synthetic thyroid hormone – daily to obese mice. The drug was packaged inside the nanogel and delivered to the mice through their abdominal cavities. After five weeks of treatment, the mice returned to a normal weight, their cholesterol levels dropped, and their liver inflammation was resolved.
An official website of the United States government.